Showing 2061-2070 of 2235 results for "".
- Galderma's Restylane Kysse FDA Approved for Lip Augmentation and Upper Perioral Rhytidshttps://modernaesthetics.com/news/galdermas-restylane-kysse-fda-approved-for-lip-augmentation-and-upper-perioral-rhytids/2472927/The FDA recently approved Galderma'a Restylane Kysse for lip augmentation and the correction of upper perioral rhytids in adults over the age of 21. Restylane Kysse is the first hyaluronic acid (HA) filler specifically indicated for the lips using XpresHAn Technology globally referred to as t
- Coping with COVID-19: Multidisciplinary Panel Offers Procedure-Specific Counsel on Reopening Aesthetic Practiceshttps://modernaesthetics.com/news/coping-with-covid-19-multidisciplinary-panel-offers-procedure-specific-counsel-on-reopening-aesthetic-practices/2472926/Certain minimally invasive aesthetic procedures including those that are lengthy, take place above the clavicle, and are considered aerosol-generating may be riskier than others in the post-COVID-19 world and will require enhanced precautions and a slower integration than procedures deemed less r
- TruSculpt Flex from Cutera Scores 2020 Good Housekeeping Awardhttps://modernaesthetics.com/news/trusculpt-flex-from-cutera-scores-2020-good-housekeeping-award/2472925/Congrats! Cutera’s truSculpt flex won a Good Housekeeping 2020 Beauty Award Winner for Ultimate Body Product. truSculpt flex is FDA-cleared for the improvement of abdominal tone, strengthening of the abdominal muscles, and development of a firmer abdomen. It is also cleared for th
- FDA Clears Bimini Health Tech’s Dermapose Access Office-Based Fat Harvesting Systemhttps://modernaesthetics.com/news/fda-clears-bimini-health-techs-dermapose-access-office-based-fat-harvesting-system/2472922/Bimini Health Tech’s received US Food and Drug Administration (FDA) 510(k) clearance for its Dermapose Access, a novel fat harvesting system. Designed for office use, the launch of the Dermapose Access system creates a new pr
- COVID-19 By the Numbers: April 28 Editionhttps://modernaesthetics.com/news/covid-19-by-the-numbers-april-28-edition-1/2472920/The CDC now lists nine potential symptoms of COVID-19, though cough and shortness of breath or difficulty breathing remain hallmarks of the disease. CDC says individuals may have COVID-19 if they experience these two symptoms plus at least two of the following: Fever
- Lumenis Virtual Conference 2020 Starts Tomorrowhttps://modernaesthetics.com/news/lumenis-virtual-conference-2020-starts-tomorrow/2472918/Those interested in learning more about the latest laser and RF technologies, seeking treatment tips, or looking to network with other practitioners may be interested in the Lumenis Virtual Conference 2020. The conference kicks off Thursday, April 23 and Friday, April 24 with live
- Cutera Closes Public Stock Offeringhttps://modernaesthetics.com/news/cutera-closes-public-stock-offering/2472917/Cutera, Inc. has closed its previously announced underwritten public offering of 2,742,750 shares of its common stock at a public offering price of $10.50 per share, which includes the exercise in full of the underwriter’s option to purchase up to an additional 357,750 shares of its co
- COVID-19 By the Numbers: April 21 Editionhttps://modernaesthetics.com/news/covid-19-by-the-numbers-april-21-edition-1/2472916/More than 300,000 Americans could die if all social distancing measures are abandoned, according to documents obtained by the Center for Public Inte
- COVID-19 By the Numbers: April 14 Editionhttps://modernaesthetics.com/news/covid-19-by-the-numbers-april-14-edition-1/2472912/Economic indicators still paint a grim picture, but the medical data suggest the US may be turning the corner in the fight against COVID-19. In fact, the US may have already reached its peak for medical resource utilization associated with COVID-19, according to estimates from the Institute
- David Long Tapped As Cynosure's Global Chief Financial Officerhttps://modernaesthetics.com/news/david-long-is-cynosures-global-chief-financial-officer/2472908/David Long is Cynosure’s new Chief Financial Officer, effective immediately. Until recently, Long served as CFO at Corindus Vascular Robotics, Inc., where he brought the company public and, ultimately, navigated its